SCOPUS 정보 검색 플랫폼

BJU International

Volumn 106, Issue 5, 2010, Pages 610-612

Evidence-based urology in practice: Composite endpoints

(3) Lavallée, Luke T a Dahm, Philipp b Breau, Rodney H a,c

a UNIVERSITY OF OTTAWA (Canada)

b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE (United States)

c MAYO CLINIC (United States)

Author keywords

benign prostatic hyperplasia; composite endpoints; evidence based medicine

Indexed keywords

DOXAZOSIN; FINASTERIDE; PLACEBO;

ADULT; ARTICLE; BIOASSAY; CASE REPORT; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; EVIDENCE BASED PRACTICE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; KIDNEY FAILURE; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; PATIENT CARE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE INDEX; RISK FACTOR; URINARY TRACT INFECTION; URINE FLOW RATE; URINE INCONTINENCE; URINE RETENTION; UROLOGY;

5-ALPHA REDUCTASE INHIBITORS; DOXAZOSIN; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; EVIDENCE-BASED MEDICINE; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATISM; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 77955896399 PISSN: 14644096 EISSN: 1464410X Source Type: Journal
DOI: 10.1111/j.1464-410X.2010.09455.x Document Type: Article

Times cited : (8)

References (7)

1
- 64249157334
- Evidence-based urology in practice: How to use PubMed effectively
- Krupski TL, Schardt CM, Fesperman SF, Dahm P. Evidence-based urology in practice: how to use PubMed effectively. BJU Int 2009 103 : 1156 9
- (2009) BJU Int , vol.103 , pp. 1156-9
- Krupski, T.L.¹ Schardt, C.M.² Fesperman, S.F.³ Dahm, P.⁴

2
- 40849102327
- How to perform a literature search
- Krupski TL, Dahm P, Fesperman SF, Schardt CM. How to perform a literature search. J Urol 2008 179 : 1264 70
- (2008) J Urol , vol.179 , pp. 1264-70
- Krupski, T.L.¹ Dahm, P.² Fesperman, S.F.³ Schardt, C.M.⁴

3
- 77955870431
- Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone
- Hoffman R. Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone. ACP J Club 2004 141 : 20
- (2004) ACP J Club , vol.141 , pp. 20
- Hoffman, R.¹

4
- 0347882750
- The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
- McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003 349 : 2387 98
- (2003) N Engl J Med , vol.349 , pp. 2387-98
- McConnell, J.D.¹ Roehrborn, C.G.² Bautista, O.M.³

5
- 77955981954
- nd edn
- nd edn.
- Composite Endpoints. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice
- Guyatt, G.¹ Montori, V.² Ferreira-Gonzalez, I.³

6
- 32944459943
- How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: Should i dump this lump?
- Montori VM, Busse JW, Permanyer-Miralda G, Ferreira I, Guyatt GH. How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump? ACP J Club 2005 143 : A8
- (2005) ACP J Club , vol.143
- Montori, V.M.¹ Busse, J.W.² Permanyer-Miralda, G.³ Ferreira, I.⁴ Guyatt, G.H.⁵

7
- 20144373791
- Validity of composite end points in clinical trials
- Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I et al. Validity of composite end points in clinical trials. BMJ 2005 330 : 594 6
- (2005) BMJ , vol.330 , pp. 594-6
- Montori, V.M.¹ Permanyer-Miralda, G.² Ferreira-Gonzalez, I.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.